Anders Bjartell
241 – 250 of 372
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2012
-
Mark
Emphasizing the role of Wnt5a protein expression to predict favorable outcome after radical prostatectomy in patients with low-grade prostate cancer
- Contribution to journal › Article
- 2011
-
Mark
Epigenetics in Prostate Cancer: Biologic and Clinical Relevance
- Contribution to journal › Article
-
Mark
Contemporary Role of Prostate Cancer Antigen 3 in the Management of Prostate Cancer
- Contribution to journal › Scientific review
-
Mark
The Contemporary Concept of Significant Versus Insignificant Prostate Cancer
- Contribution to journal › Scientific review
-
Mark
CRISP-3 AND B-MSP ON PROSTATE CANCER NEEDLE-BIOPSIES DO NOT HAVE PREDICTIVE VALUE FOR SUBSEQUENT PROSTATECTOMY OUTCOME
(2011) 26th Annual Congress of the European Association of Urology In European Urology Supplements 10(2). p.237-238
- Contribution to journal › Published meeting abstract
-
Mark
A Panel of Kallikrein Marker Predicts Prostate Cancer in a Large, Population-Based Cohort Followed for 15 Years without Screening
- Contribution to journal › Article
-
Mark
Tumor markers in prostate cancer I: Blood-based markers
- Contribution to journal › Scientific review
-
Mark
Tumour markers in prostate cancer III: Biomarkers in urine
- Contribution to journal › Scientific review
-
Mark
MicroRNA in Prostate, Bladder, and Kidney Cancer: A Systematic Review
- Contribution to journal › Scientific review
-
Mark
Elevated level of wnt5a protein in localized prostate cancer tissue is associated with better outcome.
- Contribution to journal › Article
